Stay updated on Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page’s displayed revision/version number was updated from v3.5.0 to v3.5.2. This does not indicate any change to the underlying study information.
    Difference
    0.1%
    Check dated 2026-04-22T18:20:14.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    The history section shows Revision: v3.5.0 as the latest entry, replacing the previous Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-25T01:24:52.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Added revision entry: v3.4.3; removed revision: v3.4.2 from the history.
    Difference
    0.1%
    Check dated 2026-03-10T14:16:58.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Revision history updated: added v3.4.2 and removed v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-17T01:10:36.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added to the history. The Notice about government funding and operating status was removed.
    Difference
    0.7%
    Check dated 2026-02-09T20:32:44.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    A site-wide notice banner about a lapse in government funding and the NIH Clinical Center's operating status was added at the top of the page. The banner is informational and does not modify core trial data or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2026-02-02T15:25:29.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial page.